Table 1.
Patient and tumor characteristics
| Variable | non-Xp11.2 translocation group (n = 82) | Xp11.2 translocation group (n = 16) | P value |
|---|---|---|---|
| Age(y) | 0.296 | ||
| Media(Range) | 40 (18–45) | 27 (21–40) | |
| Gender(n) | 0.086 | ||
| Male | 56 (68.3 %) | 7 (43.8 %) | |
| Female | 25 (31.7 %) | 9 (56.3 %) | |
| Size(cm) | 0.588 | ||
| Media(Range) | 4.6 (1.8–17.0) | 4.5 (3.0–11.5) | |
| Laterality(n) | 1.000 | ||
| Left | 39 (47.6 %) | 7 (43.8 %) | |
| Right | 43 (52.4 %) | 9 (56.3 %) | |
| Symptoms(n) | |||
| Asymptomatic | 57 (69.5 %) | 11 (68.8 %) | |
| Symptomatic | 25 (30.5 %) | 5 (31.3 %) | 1.000 |
| Nephrectomy (n) | 0.156 | ||
| Radical | 49 (59.8 %) | 13 (81.3 %) | |
| Partial | 33 (40.2 %) | 3 (18.8 %) | |
| Overall stage(n) | 0.026 | ||
| I | 57 (69.5 %) | 10 (62.5 %) | |
| II | 22 (26.8 %) | 2 (12.5 %) | |
| III | 2 (2.4 %) | 3 (18.8 %) | |
| IV | 1 (1.2 %) | 1 (6.3 %) | |
| TNM(2010AJCC) | |||
| T(n) | 0.026 | ||
| T1 | 57 (69.5 %) | 10 (62.5 %) | |
| T2 | 22 (26.8 %) | 2 (12.5 %) | |
| T3 | 2 (2.4 %) | 3 (18.8 %) | |
| T4 | 1 (1.2 %) | 1 (6.3 %) | |
| N(n) | 0.013 | ||
| N0 | 81 (98.8 %) | 13 (81.3 %) | |
| N1 | 1 (1.2 %) | 3 (18.8 %) | |
| M(n) | |||
| M0 | 82 (100 %) | 16 (100 %) | |
| M1 | 0 (0) | 0 (0) | |
| Tumor grade (n) | 0.011 | ||
| Low | 25 (30.5 %) | 0 (0 %) | |
| Medium | 38 (46.3 %) | 9 (56.3 %) | |
| High | 19 (23.2 %) | 7 (43.8 %) | |
| Follow-up (mo) | 0.464 | ||
| Media(Range) | 33.5 (7–71) | 29 (3–70) |